GIP (glucose-dependent insulinotropic polypeptide) improves how your body processes blood sugar and works with GLP-1 to make the "I'm full" signal stronger
In 1980 Jean-Pierre Raufman, a young gastroenterologist (figure 33), and John Pisano, a biochemist at the National Institute of Health with a fascination for venoms, began investigating the effect of peptides found in the saliva of the lizard on human physiology
High injury risk, excessive stress on cardiovascular system, poor recovery, and minimal benefit over moderate-intensity cardio for fat loss
It's particularly compelling for patients who haven't achieved adequate response with semaglutide or tirzepatide, those with obesity and concurrent knee osteoarthritis, patients with metabolic liver disease, and anyone with a significant cluster of cardiovascular risk factors
While Retatrutide is still classed as research-grade in the UK, it is generally explored by: Individuals struggling with obesity People who have plateaued on other weight-loss medications Those looking for advanced metabolic support Fitness users seeking significant body-recomposition support Important: Retatrutide is not a casual weight-loss solution
This binding extends half-life to 7 days, enabling weekly injection
